SCHEMBL5436479

SCHEMBL5436479

O=NN(c1ccc(F)cc1)c1ccc(C(=O)O)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BCL2L1 Q07817 1/20 0.57
▸ BAD Q92934 1/20 0.57
▸ MITF O75030 1/20 0.47
▸ ALDH1A1 P00352 1/20 0.47
▸ ALOX15 P16050 1/20 0.47
▸ TP53 P04637 1/20 0.44
▸ TSHR P16473 1/20 0.44
▸ TAS2R14 Q9NYV8 4/20 0.44
▸ NR4A2 P43354 1/20 0.44
▸ CES2 O00748 1/20 0.43
▸ CES1 P23141 1/20 0.43
▸ MEN1 O00255 2/20 0.43
▸ POLB P06746 2/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ NPC1 O15118 1/20 0.43
▸ LTB4R2 Q9NPC1 1/20 0.41
▸ CA1 P00915 2/20 0.41
▸ CA2 P00918 2/20 0.41
▸ SRD5A2 P31213 1/20 0.40
▸ CSNK2A2 P19784 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5443855 0.90 ALDH1A1 (0.56) ALDH1A1ALOX15TP53TSHRCES2
SCHEMBL5442604 0.84 ALDH1A1 (0.47) BCL2L1BADALDH1A1ALOX15TP53
SCHEMBL5447510 0.84 ALDH1A1 (0.47) BCL2L1BADALDH1A1ALOX15NR4A2
SCHEMBL5440597 0.84 KCNA5 (0.47) BCL2L1BADALDH1A1ALOX15TSHR
SCHEMBL5443841 0.81 MAPT (0.47) ALDH1A1ALOX15TP53TSHRMEN1
SCHEMBL5445782 0.81 SRD5A2 (0.61) ALDH1A1ALOX15NR4A2CES2CES1
Nitrous Acid SCHEMBL26134161 0.80 BCL2L1 (0.71) BCL2L1BADMITFALDH1A1ALOX15
SCHEMBL18670950 0.79 BCL2L1 (0.85) BCL2L1BADMITFALDH1A1ALOX15
SCHEMBL4570568 0.79 BCL2L1 (0.85) BCL2L1BADMITFALDH1A1ALOX15
SCHEMBL27498 0.79 BCL2L1 (0.85) BCL2L1BADMITFALDH1A1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070123586-A1 Nitroso derivatives of diphenylamine MERCK PATENT GMBH (DE) 2007-05-31 — — US claimed
EP-1687260-A1 NITROSO DERIVATIVES OF DIPHENYLAMINE MERCK PATENT GmbH (DE) 2006-08-09 — — EP claimed
WO-2005051896-A1 NITROSO DERIVATIVES OF DIPHENYLAMINE MERCK PATENT GMBH (DE) 2005-06-09 — — WO claimed
US-20070123586-A1 Nitroso derivatives of diphenylamine MERCK PATENT GMBH (DE) 2007-05-31 — — US disclosed
US-20070123586-A1 Nitroso derivatives of diphenylamine MERCK PATENT GMBH (DE) 2007-05-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070123586-A1 Nitroso derivatives of diphenylamine NOS3, CBR3, CBR1 BCL2L1 1311/4885BAD 622/4885MITF 4778/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback